Genomic Sequencing Predicts Risk of Kidney Cancer Relapse

Twelve genetic mutations in clear-cell renal cell carcinoma may predict which patients will experience recurrence; they could also help personalize adjuvant treatment, researchers say.
Medscape Medical News